Related Experiment Video

Updated: May 4, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

26.1K

Druggable targets of squamous cell lung cancer

Cheol Hyeon Kim1

  • 1Division of Pulmonology, Department of Internal Medicine, Korea Cancer Center Hospital, Seoul, Korea.

Tuberculosis and Respiratory Diseases
|January 14, 2014
PubMed

Insights

Recent advances in understanding molecular drivers of squamous cell lung cancer (SQCLC) are paving the way for targeted therapies. Genetic alterations in SQCLC are now better understood, leading to promising clinical trial results for improved patient outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Significant progress in understanding non-small cell lung cancer (NSCLC) molecular pathogenesis has reshaped treatment strategies over the last decade.
  • These advancements have primarily benefited adenocarcinoma, with less focus on squamous cell lung cancer (SQCLC).

Purpose of the Study:

  • To detail recent genetic alterations identified in squamous cell lung cancer (SQCLC).
  • To highlight the potential of targeted therapies for improving treatment outcomes in SQCLC based on emerging clinical trial data.

Main Methods:

  • Review of recent genetic findings in SQCLC.
  • Analysis of clinical trial outcomes for targeted agents in SQCLC.

Main Results:

  • Identification of key genetic alterations specific to SQCLC.
  • Positive clinical trial results demonstrating efficacy of targeted agents in SQCLC.

Conclusions:

  • Targeted therapies based on identified genetic alterations show promise for improving SQCLC treatment.
  • Further research into SQCLC molecular pathogenesis is crucial for advancing personalized medicine in lung cancer.
Keywords:
Carcinoma, Squamous CellLung Neoplasms

More Related Videos

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

11.4K
Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma12:03

Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma

Published on: July 25, 2011

20.6K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.2K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
81
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.4K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.7K